Coronavirus (COVID-19) Advocacy
The ADA is lobbied Congress and the administration to protect dental patients and staff who are providing urgent and emergency care during the COVID-19 pandemic. The ADA is also lobbed to help dental practices stay viable during (and following) prolonged periods of reduced hours or closure. Visit ada.org to learn more about the Coronavirus (COVID-19) advocacy efforts.
ADA defends safety and efficacy of fluoride supplements amid FDA review
Jul 11, 2025
ADA leaders are emphasizing the evidence-based effectiveness and safety of fluoride supplements in comments submitted o the FDA.
https://adanews.ada.org/ada-news/2025/july/ada-defends-safety-and-efficacy-of-fluoride-supplements-amid-fda-review/
